moderate diabetic retinopathy
Showing 9976 - 10000 of >10,000
Alzheimer Trial in Montpellier (Photobiomodulation REGEnLIFE RGn530 device, SHAM REGEnLIFE RGn530 device)
Terminated
- Alzheimer Disease
- Photobiomodulation REGEnLIFE RGn530 device
- SHAM REGEnLIFE RGn530 device
-
Montpellier, FranceMontpellier University Hospital, Gui de Chauliac
Jul 10, 2020
Type 1 Diabetes Trial in Belfast (Administration ofOxygen and carbon dioxide, Administration of Oxygen and carbon dioxide)
Withdrawn
- Type 1 Diabetes Mellitus
- Administration ofOxygen and carbon dioxide
- Administration of Oxygen and carbon dioxide
-
Belfast, Antrim, United KingdomDepartment of Therapeutics and Pharmacology, Queens University B
Aug 16, 2019
Alzheimer Trial in Brisbane (Regulatory T cells, Saline)
Unknown status
- Alzheimer Disease
- Regulatory T cells
- Saline
-
Brisbane, Queensland, AustraliaBht Lifescience Australia Pty Ltd
Aug 2, 2019
Diabetic Macular Edema Trial in Guangzhou (Ranibizumab)
Unknown status
- Diabetic Macular Edema
-
Guangzhou, Guangdong, ChinaKunbei Lai
Jun 2, 2019
Molecular Pathways Involved in Knee Pain
Unknown status
- Knee Osteoarthritis
- Knee Pain Chronic
- Quantitative Sensory Testing
- +6 more
-
Nottingham, Nottinghamshire, United KingdomThe University of Nottingham, City Hospital Campus
Nov 10, 2020
Onychomycosis of Toenail Trial in South Miami (Next Science Treatment Gel)
Unknown status
- Onychomycosis of Toenail
- Next Science Treatment Gel
-
South Miami, FloridaDoctors Research Network
Jul 31, 2019
Type 1 Diabetes Trial in Salt Lake City (Propranolol 80 Mg Oral Capsule, Extended Release, Placebo oral capsule)
Terminated
- Type 1 Diabetes Mellitus
- Propranolol 80 Mg Oral Capsule, Extended Release
- Placebo oral capsule
-
Salt Lake City, UtahUniversity of Utah
Aug 7, 2020
Type 2 Diabetes, Proteinuria Trial (Dipeptidyl Peptidase 4 Inhibitor, Sulfonylurea)
Completed
- Type 2 Diabetes Mellitus
- Proteinuria
- Dipeptidyl Peptidase 4 Inhibitor
- Sulfonylurea
- (no location specified)
Jun 12, 2019
s and Need of Pharmacological Treatments in Attention Deficit
Completed
- Attention Deficit Hyperactivity Disorder
- Youths
-
Montpellier, FranceUhmontpellier
Jul 28, 2020
Diabetic Cardiomyopathy, Diabetes Type 2 Trial in Rome (Tadalafil, Placebo)
Completed
- Diabetic Cardiomyopathy
- Diabetes Mellitus Type 2
- Tadalafil
- Placebo
-
Rome, ItalyDipartimento di Medicina Sperimentale - Sezione di Fisiopatologi
Jul 9, 2019
Cerebral Palsy Trial in Denmark (Magnesium sulphate)
Completed
- Cerebral Palsy
- Magnesium sulphate
-
Hvidovre, Danmark, Denmark
- +13 more
Aug 13, 2019
Moderate Active Ulcerative Colitis Trial in Japan (E6007, Placebo)
Completed
- Moderate Active Ulcerative Colitis
- E6007
- Placebo
-
Nagakute, Aichi, Japan
- +63 more
Oct 3, 2019
Diabetic Foot Trial in Leon (Chlorhexidine gluconate at 0.125%, Placebo Comparator with physiological saline sterile solution)
Unknown status
- Diabetic Foot
- Chlorhexidine gluconate at 0.125%
- Placebo Comparator with physiological saline sterile solution
-
Leon, Guanajuato, MexicoUniversidad de Guanajuato
Mar 13, 2019
Atopic Dermatitis Trial in United States (Treatment with Halobetasol propionate 0.05% topical spray)
Terminated
- Atopic Dermatitis
- Treatment with Halobetasol propionate 0.05% topical spray
-
North Hollywood, California
- +12 more
Sep 24, 2019
COPD Trial in Hines (Breathing retraining plus exercise, Exercise only)
Completed
- COPD
- Breathing retraining plus exercise
- Exercise only
-
Hines, IllinoisEdward Hines Jr. VA Hospital, Hines, IL
Sep 11, 2019
Stress Trial in Seattle (Mindful Awareness in body-oriented therapy)
Completed
- Stress
- Mindful Awareness in body-oriented therapy
-
Seattle, WashingtonUniversity of Washington
May 11, 2020
Ab Interno Gelatin Stent With Mitomycin C Using Targeted
Completed
- Glaucoma
- XEN-45 gelatin microstent
-
Oakville, Ontario, CanadaPrism Eye Institute
Aug 4, 2020
How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic
Completed
- Diabetes
- Diabetes Mellitus, Type 1 Diabetes
- Fast-acting insulin aspart
-
Schweinfurt, GermanyNovo Nordisk Investigational Site
Mar 17, 2020
Rheumatoid Arthritis Trial in Worldwide (Baricitinib, Methotrexate, Baricitinib Placebo)
May-Thurner Syndrome, Peripheral Vascular Disease, Venous Disease Trial in Worldwide (VENOVO™ Venous Stent)
Completed
- May-Thurner Syndrome
- +3 more
- VENOVO™ Venous Stent
-
Darien, Connecticut
- +20 more
Jan 14, 2021
Atopic Dermatitis Trial in Pierre-Bénite (ROUVAX, )
Completed
- Atopic Dermatitis
- ROUVAX
- placebo
-
Pierre-Bénite, Lyon, FranceUnité de Recherche Clinique et Immunologique
Feb 11, 2020
Postoperative Complications Trial in Evanston (Control-saline, Dexamethasone 4 mg, Dexamethasone 8 mg)
Completed
- Postoperative Complications
- Control-saline
- +3 more
-
Evanston, IllinoisNorthShore University HealthSystem
Sep 12, 2019